株価
28.82
毎日の変更
0.20 0.70%
毎月
2.27%
毎年
17.06%
Q1 予測
27.72




負債 変化する 日付
argenx SE USD 43.15M 4.1M 2025-06
AstraZeneca USD 32.63B 207M 2025-09
Biogen USD 6.29B 1.7M 2025-12
Genmab DKK 148M 5M 2025-06
Gilead Sciences USD 24.94B 5M 2025-09
GlaxoSmithKline GBP 17.75B 396M 2025-09
GRIFOLS EUR 8.82B 1.23B 2025-06
Hikma Pharmaceutical USD 1.56B 252M 2025-06
Incyte USD 40.41M 855K 2025-12
Merck EUR 12.1B 2.7B 2025-09
Neurocrine Biosciences USD 428.4M 10.7M 2025-09
Novartis USD 32.64B 1.37B 2025-06
Roche Holding CHF 33.03B 1.41B 2025-06
Sanofi EUR 21.76B 530M 2025-09
UCB EUR 3.03B 12M 2024-12
Vertex Pharmaceuticals USD 1.83B 307.4M 2025-09